Compounds > 3,4-dihydroxyphenylethanol
Page last updated: 2024-08-25

3,4-dihydroxyphenylethanol and Acute Kidney Failure

3,4-dihydroxyphenylethanol has been researched along with Acute Kidney Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, Y; Fang, Q; Jiang, DS; Zhang, Y1
Ai, Q; Chen, C; Wei, Y1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylethanol and Acute Kidney Failure

ArticleYear
Hydroxytyrosol inhibits apoptosis in ischemia/reperfusion-induced acute kidney injury via activating Sonic Hedgehog signaling pathway.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23

    Topics: Acute Kidney Injury; Animals; Apoptosis; Cell Survival; Cells, Cultured; Disease Models, Animal; Hedgehog Proteins; Humans; Male; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction

2020
Hydroxytyrosol protects against cisplatin-induced nephrotoxicity via attenuating CKLF1 mediated inflammation, and inhibiting oxidative stress and apoptosis.
    International immunopharmacology, 2021, Volume: 96

    Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line; Chemokines; Cisplatin; Humans; Kidney; Male; MARVEL Domain-Containing Proteins; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol

2021